Joost P G Sluijter
Overview
Explore the profile of Joost P G Sluijter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
212
Citations
6315
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Davidson S, Andreadou I, Antoniades C, Bartunek J, Basso C, Brundel B, et al.
Cardiovasc Res
. 2025 Mar;
PMID: 40084813
Animal models offer invaluable insights into disease mechanisms but cannot entirely mimic the variability and heterogeneity of human populations, nor the increasing prevalence of multi-morbidity. Consequently, employing human samples-such as...
2.
Demkes E, Cervera-Barea A, Ebner-Peking P, Wolf M, Hochmann S, Scheren A, et al.
J Cardiovasc Transl Res
. 2025 Mar;
PMID: 40082315
Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) constitute a promising therapy for myocardial infarction (MI). The lack of an effective immunosuppressive regimen, combined with single-cell transplantations, results in suboptimal outcomes, such...
3.
Xiao J, Sluijter J
Nat Rev Cardiol
. 2025 Mar;
PMID: 40045042
Communication between multicellular organs is essential to propagate signals and coordinate their function. Over the past decade, the role of extracellular vesicles in the molecular communication between cells in both...
4.
Maas R, Lee S, Harakalova M, Snijders Blok C, Goodyer W, Hjortnaes J, et al.
STAR Protoc
. 2025 Feb;
6(1):103679.
PMID: 40019838
No abstract available.
5.
Zhang X, Ye X, Xie Y, Yang Z, Spanos M, Guo Z, et al.
Research (Wash D C)
. 2025 Feb;
8:0609.
PMID: 39949511
The prevention of air pollution-related cardiopulmonary disorders has been largely overlooked despite its important burden. Extracellular vesicles (EVs) have shown great potential as carriers for drug delivery. However, the efficiency...
6.
Vicente P, Inocencio L, Ullate-Agote A, Louro A, Jacinto J, Gamelas B, et al.
Adv Sci (Weinh)
. 2025 Jan;
e2410510.
PMID: 39846380
Generation of upscaled quantities of human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM), for therapeutic or testing applications, is both expensive and time-consuming. Herein, a scalable bioprocess for hiPSC-CM expansion in stirred-tank...
7.
Correction: Vitamin C facilitates direct cardiac reprogramming by inhibiting reactive oxygen species
Fang J, Yang Q, Maas R, Buono M, Meijlink B, Bruinenberg D, et al.
Stem Cell Res Ther
. 2024 Dec;
15(1):500.
PMID: 39719639
No abstract available.
8.
Atash A, Cramer M, Mees B, Doevendans P, Sluijter J, Stillitano F
Stem Cell Res
. 2024 Dec;
82():103630.
PMID: 39705883
A novel pathogenic variant in the MYH11 gene (c.4559+1G>A) leading to exon 32 skipping, is a rare cause of familial aortic aneurysms and dissections (fTAAD). The phenotype has proven highly...
9.
Rekker L, Renkema E, Hilverda F, van Laake L, Doevendans P, Sluijter J, et al.
Heart Rhythm O2
. 2024 Nov;
5(10):747-749.
PMID: 39524059
No abstract available.
10.
Vervoorn M, van Tuijl S, Ballan E, Kaffka Genaamd Dengler S, de Jager S, Sluijter J, et al.
J Heart Lung Transplant
. 2024 Nov;
PMID: 39490458
Background: A common limitation to normothermic ex situ heart perfusion (ESHP) is functional decline. We previously designed a cardioprotective normothermic perfusion protocol, incorporating adenosine-lidocaine cardioplegia, subnormothermic reperfusion, pyruvate and methylprednisolone...